HL301
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for HL301, covering 2014-09-26 to 2020-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients [Phase 2]